ATARGET EIRL

ATARGET EIRL is a communications agency specifically focused on privately owned pharmaceutical and life science companies. Essentially our clients have two missions: develop revolutionary products that will improve the lives of patients worldwide and provide a return on investment. These two missions are in no way contradictory. ATARGET works at the interface between these two missions. ATARGET helps emerging pharmaceutical and life science companies market themselves as investment opportunities to potential partners and key actors in the financial industry. We work with companies to identify their investment thesis, a memorable story which highlights the medical need and potential market for their products, while demonstrating a clear route to profitability. ATARGET contributes considerable experience from finance and investor and media relations. We have managed effective communications campaigns for important clinical results, financings, partnership agreements, as well as mergers and acquisitions. We can target your news to the specialist life science and generalist media and prepare management for inevitable setbacks and increasing scrutiny from key audiences. Our primary aim is to facilitate your access to scarce capital and resources. At the same time we implement integrated communications strategies, involving scientists, physicians and your potential customers.